Our guest in this episode is Michael Kelly.
Mike is the Director of Bio-process Engineering at Hart Design Group, where he has been leading innovative process solutions. With a career spanning top-tier biotech and engineering firms like Parsons Corporation, Biogen, Amgen, and Moderna, Mike has held increasingly senior roles across engineering, project management, and facilities operations.
He has a degree in Chemical Engineering from Widener University, and an MBA from Bentley University. He brings technical acumen along with strategic thinking which were abundantly clear in this interview. Michael enjoys traveling, ice hockey, golf, and a good book.
In this chat, Mike and Samir Gondalia discuss
– the evolving landscape of the pharmaceutical industry,
– the facility retrofitting and the integration of new technologies,
– the importance of flexibility in facility design,
– the role of innovative tools like 3D scanning and augmented reality, and
– the challenges of managing operations during retrofitting.
Takeaways
- The pharmaceutical industry is shifting towards retrofitting existing facilities rather than building new ones.
- Flexibility in facility design is crucial to accommodate various modalities and future needs.
- 3D scanning technology enhances the retrofitting process by providing accurate facility layouts.
- Logistics planning is essential to minimize disruptions during facility upgrades.
- Underrated causes of delay often stem from site conditions and communication issues.
- Choosing an engineering partner with in-house capabilities can streamline project execution.
- Proactive planning is necessary to avoid disruptions in GMP operations during retrofitting.
- Collaboration with trades and construction teams is vital for successful project outcomes.
- Utilizing augmented reality (AR) can improve rigging and installation processes.
- Future-proofing facilities requires anticipating scientific advancements and designing accordingly
Quotable quotes:
“It’s all about time and money.”
“Logistics planning is crucial.”
Additionally, we highlight underrated causes of project delays and provide insights on how life science companies can choose the right engineering partners to ensure successful project execution.
Mike can be reached at mkelly(at)hartcompanies.com and on LinkedIn.
Here’s Michael Kelly.